Genetic control of cellular and humoral immune responses to pathogenic viruses has been studied using several different types ofviruses and a few host species (reviewed in references [1] [2] [3] [4] [5] . Most ofthese studies, however, focused on the recognition ofviral antigens on infected target cells by cytotoxic T cells, and little is known about how the induction of immune responses to pathogenic viruses is genetically controlled (4, 5) . Of course, immune response (Ir)t gene phenomena have been described and their mechanisms have been intensively analysed using synthetic and natural antigens of limited numbers of antigenic determinants (reviewed in references 6 and 7). Consequently, it has been considered likely that Ir gene phenomena control host immune responses to viral antigens through the mechanisms quite similar to what have been observed with synthetic peptides (5, 8) . In fact, the presence of viral antigenspecific, H-21 region-restricted helper T cells has been demonstrated in mouse models of influenza virus (4, 9) , Sendai virus (5), reovirus (10) , and herpes simplex virus (11, 12) infections . However, direct demonstration ofIr gene-controlled responder/nonresponder phenotypes to viral antigens has been rarely presented (13) , except in the humoral immune responses of inbred mice to human hepatitis B virus surface antigen (14, 15) . In the present study we have investigated cellular mechanisms for the influence of H-2 on the induction ofprotective immunity against murine retrovirus infection and identified H-2-linked Ir genes controlling the T cell responsiveness to the viral envelope glycoprotein .
Friend murine leukemia virus complex (FV) is a retrovirus complex composed ofreplication competent Friend murine leukemia helper virus (FMuLV) and defective Friend spleen focus-forming virus (SFFV) (16) . FV causes extremely rapid progression of an erythroleukemia associated with severe immunosuppression when injected to immunocompetent adult mice or newborn mice of susceptible strains (17, 18) . This FVinduced leukemia usually results in massive splenomegaly occurring [1] [2] Ir GENE CONTROL OF ANTI-FRIEND MuLV T CELL RESPONSE wk after virus inoculation and in death of infected animals within 1-3 mo. However, in certain mouse strains, spontaneous recovery from leukemic splenomegaly occurs 2-4 wk after virus inoculation and recovered mice show long-lasting resistance to FV (17, 19) . The production of antiviral antibodies is required for the recovery and is associated with the clearance of viremia (20, 21) . In addition, we have detected both cytotoxic effector cells and proliferative L3T4+ cells specific for FVinduced leukemia cells in FVinfected mice (22) (23) (24) . In FVinfected mice, a gene(s) in H-2K or I region influences the ability to generate leukemia cell-specific proliferative T cells, whereas the H-2D locus appears to control the time course of development of this T cell response (24) . More recently we studied protective immunization of mice against FV with a recombinant vaccinia virus that expressed the env gene of F MuLV (25, 26) . By using several H-2 recombinant mouse strains, a gene or genes in H-2K or I region was shown to control the development of protective immunity after immunization with the vaccinia-F-MuLV env (26) . Moreover, this protective immunity was functionally mediated by priming of helper T cells (25, 26) .
These results strongly suggest that a gene(s) in H-2K or I region controls T cell responsiveness to the FMuLV env gene products . In this paper we provide direct evidence that H-2I region (class II loci) gene products expressed on APCs function as the restriction elements for the T cell recognition of F MuLV envelope protein . To eliminate possible effects of the Rfv-3 gene (21, 27) on T cell and/or APC functions, all mice used in this study were F, hybrids with the Rfv-3* ir genotype . F, hybrid mice were bred at the Rocky Mountain Laboratories (RML), Hamilton, MT. H-2 alleles and parameters of anti-FV immune responses of the H-2 congenic and recombinant mice used in this study are summarized in Table I . Both male and female mice 2-6 mo old were used ; however, all sources of APC and T cells were age and sex matched in each experiment .
Purified Viruses . Sucrose density purified virions of Rauscher murine leukemia virus (R MuLV) from JLS-V9 leukemia cell line (No. 1089 and 1090) were kindly provided by the Biological Carcinogenesis Program, National Cancer Institute, Frederick Cancer Research Facility, Frederick, MD. Virions of an infectious molecular clone of F MuLV, FB-29 (29) , were purified from culture supernatant of chronically infected, Fischer rat embryo (FRE) cells or Mus dunni cells by using a previously described Percoll density gradient method (30) . Purity ofthe virions was confirmed by SDS-PAGE. FV and Rauscher virus complex are biologically quite similar (16) and FMuLV and RMuLV are immunologically highly crossreactive sharing a large number of antigenic determinants (31, 32) . Therefore, we used both of these virus strains to test FMuLV-specific T cell responses . Purified virions were dialyzed against Dulbeccds PBS without the divalent cations (D-PBS-), and were inactivated by UV irradiation (33) . Inactivation of plaque-forming activity was determined by a focal immunofluorescence assay (34) on live Mus dunni cells .
Preparation of TNP-KLH. TNP haptens were conjugated to KLH (Calbiochem-Behring Corp., La Jolla, CA) by a standard method (35) . The preparation used in this study was conjugated with 7 .7 mol TNP/105 g KLH .
Immunization ofMice. Mice were immunized in the hind foot pads with 100 pg of the virions or TNP-KLH emulsified in CFA (Difco Laboratories, Inc., Detroit, MI). The recombinant vaccinia virus expressing the entire env gene from the FMuLV clone 57 (25) and the control recombinant vaccinia virus expressing the influenza hemagglutinin (HA) gene (36) were kindly provided by Dr. Bernard Moss, Laboratory of Viral Diseases, National Institute of Allergy Preparation ofAPCs. Peritoneal exudate cells (PEC) were elicited by intraperitoneal injection of 0 .5-1 .0 ml 2 .5% oyster glycogen (Type II ; Sigma Chemical Co., St. Louis, MO) in D-PBS - (37) . PEC were harvested 3-4 d after the injection and were irradiated (2,000 rad) in a 137CS y-irradiator. Irradiated PEC were washed once, suspended at 10 7 cells/ml in prewarmed phosphate buffered balanced salt solution (PBBS) containing 10% FCS of a lot selected for low background stimulation of DNA synthesis (HyClone Laboratories, Inc ., Logan, UT) and were pulsed with an antigen at 37'C for i h . Antigen-pulsed PEC were washed once with cold D-PBS -and three times with cold PBBS. Control unpulsed PEC were prepared by exactly the same procedure except that D-PBS -was added to prewarmed PBBS instead of an antigen.
The APC activity of glycogen-elicited PEC was confirmed by comparison with that of spleen adherent cells analyzing stimulator cell dose-response curves, and the glycogen-elicited PEC were usually better as APC than spleen adherent cells were. Therefore, we used these PEC as APC in all the following experiments .
Antigen dose-response curves of T cell proliferative response were analyzed in preliminary experiments for TNP-KLH and purified virions. In both cases, resultant dose-response curves were rather flat throughout the concentration range from 10 to 100 Pg/ml, and the highest magnitude of proliferation was observed when PEC were pulsed with 100 wg/ml of antigen . Therefore, this concentration was used to pulse PEC throughout further experiments .
T Lymphocyte Proliferative Assay. Nylon wool-passed T cells were prepared by a standard technique (35, 38) from the pooled spleens and lymph nodes of two to three mice from immunized and unimmunized control groups . The average composition of the nylon wool-passed (24), it was postulated that T cells in H-2°m ice could not be primed with the F-MuLV antigens . To test whether T cells could recognize the viral antigens in the context of H-2a MHC molecules, we first examined proliferative response of nylon wool-purified T cells from immunized H-2" mice under the stimulation of H-2 a and H-2" PEC . Because of the availability of a large quantity of purified virions, R MuLV, which is highly crossreactive with FMuLV, was used to immunize mice along with CFA. As shown in Fig. 1 , H-d" PEC pulsed with UV-irradiated RMuLV induced three to four times higher peak proliferative response of RMuLV-primed H-2`T cells than pulsed H-2 a PEC did . This difference in APC activity to RMuLV-primed H-2" T cells between H-2°and H-2' PEC was not because of the difference in kinetics of T cell proliferation because both under the stimulation of H-2°PEC and under the stimulation of H-2" PEC the peak of thymidine incorporation was observed when [3 H]thymidine was added on day 3 (data not shown). RMuLV-specific T cell proliferative responses were analyzed repeatedly from 17 to 31 d after priming of the H-21 mice and peak Ocpm values under the stimulation of H-2' or H-2' PEC were always three to seven times higher than those under the stimulation of H-21° PECs (Table II) . Therefore, the observed difference in APC activity between H-21 '°a nd H-2b4 PEC was not caused by a difference in the time course of priming between H-2a-restricted and H-2b-restricted T cell populations. Thus, these results clearly showed that the PEC having the H-2b haplotype were more efficient than those having only the H-2°haplotype to present the viral antigens to RMuLVprimed H-2" T cells. In addition, there was no significant difference between the APC activity of heterozygous H-2 b PECs and that of homozygous H-Z" PEC to RMuLVprimed T cells, confirming the dominance of H-2b haplotype. Stimulator cell dose-response curves were analyzed in all of these experiments and the data are represented by peak proliferative response . No significant proliferative response of T cells from unimmunized control mice under the stimulation of R-MuLV-pulsed PEG was observed in any of these experiments . PEG were pulsed with UV-irradiated R-MuLV . Acpm values in boxes are significantly higher than those under the stimulation of H-2d°P EC in each experiment (p < 0.05 by Student's t test). Proliferative Response of T Cells Primed with TNP-KLH. To eliminate the possibility that the above-described difference in the R-MuLV-primed T cell proliferative response under the stimulation of H-daa and H-266 PEC was a result of general functional impairment of H-21°PEC, we tested the proliferative response of H-Z" T cells primed with TNP-KLH as a control antigen. As shown representatively in Fig.  2 , there was no general impairment in APC activity of H-2°PEC, compared with that of H-2b b PEC, that could explain the three to sevenfold difference in R-MuLVspecific T cell proliferative response.
Proliferative Response ofF-MuLVEnvelope-speck T Cells under the Stimulation of H-2a and H-2"b PEC Purified R-MuLV virions used as immunogens in the previous experiments contain envelope, core, and polymerase proteins . However, earlier studies (25, 26) indicated that the FMuLV envelope protein by itself could induce protective immunity against FV Furthermore, H-2 haplotype had a significant influence on induction ofthe protective immunity with the vaccinia-FMuLV env vaccine (26) . Therefore, to analyze the influence of the H-2 on APC control of the FMuLV envelope-specific T cell response, we immunized mice with the recombinant vaccinia virus that expressed the entire FMuLV env gene, but not the gag or pol genes. T cells from the H-dab mice immunized with the vaccinia-FMuLV env proliferated under the stimulation of H-2"b PEC pulsed with UVirradiated FMuLV (FB-29) or RMuLV, and there was no significant difference in the stimulator cell dose-response curves (Fig . 3, A and B ) or in the antigen dose-response curves (not shown) obtained using these two virus strains, confirming the crossreactivity of the viruses at the T cell level. Importantly, while H-2111 PEC induced significant proliferative responses of FMuLV envelope-specific T cells, only marginal proliferative responses were observed when the T cells were stimulated with H-2a PEC (Fig. 3) . The T cells from the H-dab mice immunized with the control vaccinia-influenza HA did not To determine the gene locus (or loci) within the H-2 that influences the APC activity to FMuLV envelope-specific T cells, we first tested several H-2 recombinant mouse strains as the sources of PEC. As shown in Fig. 4 To distinguish the possible influence of the b allele at the K locus from that of the b allele at the AD, A,, and /or Ep loci, we next used the B10.MBR strain of mice that has a recombination between the K and Ap loci of the H-2 (see Table I ). When PEC from (B10.MBR x A.BY)Fi and (B10 .MBR x A/WySn)Fl mice were used to stimulate H-2b T cells primed specifically for F-MuLV envelope protein, significantly higher envelope-specific proliferative responses were observed under the stimulation of(B10.MBR x A.BY)Fj (Kb1b, IAk 1b) PEC (Table III) . Thus, the PEC having the b allele both at the K and I-A loci were more efficient at presenting the antigen to FMuLV envelope-specific T cells than were the PEC having the b allele only at the K locus. However, the Acpm values obtained under the stimulation of In some experiments mice were boosted 3 mo later by repeating the same immunization . The spleen and lymph node cells from two immunized mice were pooled to prepare T cells in each experiment . 1 Stimulator cell dose-response curves were analyzed in each of these experiments and the results are represented here by peak Acpm values . 4 These Acpm values are significantly higher than the other value of the same experiment (p < 0 .05 by Student's t test) . T cell preparations, syngeneic T cell proliferative responses were analyzed using both immune T cells and PEC from (B10 . (Fig . 6A ) both of the two anti-I-Al mAbs strongly inhibited the FMuLU envelope-specific T cell proliferative response, whereas the anti-I-E k and anti-Kb mAbs did not. When H-2" PEC were used to stimulate the envelope-specific T cells (Fig. 6 B) , both the anti-I-A' mAbs, again, significantly inhibited the proliferative response . However, more importantly, the anti-I-Ak mAb did not block the proliferative response at all (arrow), and neither the anti-Kb nor the anti-Kk mAb inhibited the envelope-specific T cell proliferation. Interestingly, anti-I-Ek mAb 14-4-4S exhibited an intermediate inhibitory effect on the envelope-specific T cell proliferative response (arrow) .
The lack of inhibition of the FMuLU envelope-specific T cell proliferative re- sponse under the stimulation of H-211 PECs with the anti-I-A' mAb was not because we used an antibody of inappropriate specificity or inadequate affinity. Fig.  6 , C-E show the results of control experiments in which the inhibition of TNP-KLH-specific T cell proliferative response was analyzed . As shown in Fig. 6 , C-E, the anti-I-A and anti-I-E mAbs used in these experiments had appropriate haplotype specificity and adequate affinity to inhibit T cell proliferative responses. Moreover, all the anti-I-A and anti-I-E mAbs used inhibited the T cell proliferative response through their binding to APC, but not by the binding to T cells, because only the mAbs directed to MHC antigens expressed on PEG, but not the mAbs directed to the MHC molecules that are expressed on T cells but absent on PEG, inhibited the proliferation (Fig. 6 , compare C and E) . Thus, these results directly indicate that FMuLV envelope-specific T cells from H-2" mice recognize the envelope protein in association with I-Ab, hybrid I-A, and/or hybrid I-E" class II MHC molecules expressed on APC. bm12 Mutation Abolished T Cell Responsiveness to F-MuLV Envelope Protein. Both of the anti-I-Ab mAbs that inhibited the FMuLV envelope-specific T cell proliferative responses under the stimulation of H-2db PEG in previous section do not react with the mutant I-A molecule of B6.C-H-2''" 12 (bm12) mice (44) . This mutation occurred in the 01 exon of the Apb gene (45, 46) . Therefore, it was of interest to test whether the presence of wild-type Apb chain was essential for the recognition of FMuLV envelope glycoprotein by T cells. We hence immunized both (B10 .A x A.BY)Fi (H-2) and (bm12 x A/WySn)Fi (H-2'"' 12' mice with the vaccinia-FMuLV env vaccine, and tested the envelope-specific T cell proliferative responses under the stimulation ofPECs elicited from these two strains ofmice. T cells from immunized (B10 .A x A.BY)Fj mice, again, proliferated strongly under the stimulation of syngeneic PEG pulsed with FMuLV (Fig . 7) . However, T cells from immunized (bm12 x A/WySn)Fi mice did not show any significant envelope-specific proliferative responses both under the stimulation of syngeneic PEG and under the stimulation of H-2al' PEG (Fig. 7, squares) . Therefore, T cells were not primed with FMuLV envelope protein in H-2'm" mice .
The envelope-specific proliferative responses of H-gal' T cells under the stimulation of H-2'-" PEG were significantly lower than those under the stimulation of syngeneic PEG (Fig. 7 and Table IV ). In three of the five repeated experiments, the Acpm values obtained under the stimulation of H-2b-11 PEG were marginal . However, relatively high level of envelope-specific proliferative responses were observed in two other experiments (Table IV) . Thus, the expression of wild-type ADb chain was definitely required to prime T cells with FMuLV envelope protein in vivo, and antigen-presenting activity of H-2b -11 PECs to the envelope-specific T cells was, at least, lower than that of H-2alb PEG, but we could not distinguish whether the lack of T cell priming with FMuLV envelope protein in H-2b" 21" mice was due to a restricted T cell repertoire or reduced antigen-presenting activity to envelope-specific T cells, or both. H-2°haplotype cannot (Fig. 3) . This phenomenon is not caused by general functional impairment of APC having the H-2°genotype because in the control experiments H-Z" APC presented the antigen to TNP-KLH-primed T cells as effectively as H-2' APC did (Fig. 2) . Genetic mapping experiments show that the gene(s) controlling the antigen-presenting activity to FMuLV envelope-specific T cells is located in K-or I-region loci of the H-2 (Fig. 4) . Moreover, T cells in (B10 .MBR x A/WySn)F1 mice that have the Kbik, I-A' genotype cannot be primed with the envelope antigen (Fig. 5) . The most likely explanation for this influence of the H-2 on antigen-presenting activity is that FMuLV envelope-specific T cells in H-2alb The schedule of immunization was the same as that described in Table III . t Stimulator cell dose-response curves were analyzed in each of these experiments and the results are represented here by peak Acpm values . 5 These Acpm values are significantly higher than the other value of the same experiment (p < 0.05 by Student's t test) . mice recognize the envelope protein only in association with I-A', hybrid I-A", and/or hybrid I-E' molecules.
To demonstrate directly that these class II MHC molecules were actually functioning as restriction elements in the recognition of FMuLV envelope antigen by T cells, we did blocking experiments with anti-H-2 mAbs (Fig . 6) . Both of the two anti-I-Ab mAbs used strongly inhibited the FMuLV envelope-specific T cell proliferative response under the stimulation of H-2' or H-26ib PEC, while the antiKb, anti-Kk , and, more importantly, anti-I-Ak mAbs did not block even when the T cells were stimulated with heterozygous H-2" PEC. Since both of the anti-I-Ab mAbs used in this study do not react with the mutant I-A molecule of bm12 mice (44) , the presence of wild-type Apb chain seems to be essential for the formation of the antigenic determinants recognized with these mAbs . In addition, the antigenic determinant recognized with anti-I-Ak mAb 10-3 .6 is located on AO k chain (47) . Therefore, within the limitation of mAbs used, the results of our blocking experiments, along with the results obtained with the H-2 recombinant mice, indicate that AabApb and possibly A,'Apb class II molecules are the restriction elements for FMuLV envelope-specific T cells, while AakApk and AabApk molecules are not.
Importance of Apb chain in T cell recognition of FMuLV envelope protein is further substantiated by the experiments using the mutant bm12 mice. T cells are not primed with the envelope antigen in (bm12 x A/WySn)Fi mice (Fig. 7) , and FMuLV envelope-specific T cells from H-Z" mice are more efficiently stimulated with syngeneic PEC than with IA'-" PEC ( Fig . 7 and Table IV) . Therefore, Apb chain seems to play a critical role in stimulation of FMuLV envelope-specific proliferative T cells. In addition, although (bm12 x A/WySn)Fl PEC are thought to express A a bApk hybrid class II molecules along with AabApbml2, AakApbmt2, and AakApk molecules, there is no complementation effect by this hybrid I-A molecule to stimulate the envelope-specific T cells. This result further supports the conclusion that A abAp k molecule is not involved in T cell recognition of F-MuLV envelope antigen. Since H-gala APC that express I-Ek as well as I-Ak molecules cannot present the envelope glycoprotein to specifically primed T cells, it is a somewhat unexpected finding that anti-I-Ek mAb 14-4-4S induced intermediate, but statistically significant, inhibition of the envelope-specific T cell proliferative response under the stimulation of H-2alb PEC (Fig . 6 B) . However, since this mAb has specificity of Ia.7 (43) and the antigenic determinant for this specificity is expressed on the Eak subunit (8) , this inhibitory effect is probably mediated by a steric effect caused by binding of the mAb to Eak chain of the EakEpb complex. Thus, it is likely that, in addition to I-Ab-and hybrid I-Alb-restricted T cells, some (small) population of FMuLV envelope-specific T cells in H-2' mice do recognize the antigen in the context of EakEpb . Marginal proliferative responses of H-2" T cells under the stimulation of H-2b,r21a PEC might also be mediated by this hybrid I-E molecule .
The envelope protein of FMuLV is a large, complex molecule that is composed of 675 amino acids and several carbohydrate chains (48) , and it has at least several different antigenic determinants distinguishable with mAbs (31, 32, 49, 50) . It is, therefore, quite surprising that the same molecule does not have any T cell determinants that can be recognized in association with H-2a MHC products . From the results of their extensive analyses on the interaction between protein-derived immunogenic peptides and class II MHC molecules, Buus et al . (51) have calculated that each class II molecule can bind >50% of immunogenic peptides of 10-17 amino acids and even 10-20% of unbiased (not only immunogenic) small peptides . In this regard, it would be difficult to imagine that none of the peptides derived from such a big molecule as FMuLV envelope glycoprotein can be bound by I-Ak or I-Ek molecule. On the other hand, since envelope glycoprotein ofendogenous murine leukemia viruses is expressed as a differentiation antigen during the normal development of hematopoietic precursor cells and reproductive systems (52, 53) , it is possible that T cell repertoire for recognition of the FMuLV envelope protein is somewhat restricted by self-tolerance to endogenous retroviral antigens . In fact, lack of T cell responsiveness to FMuLV envelope protein in (bm12 x A/WySn)Fl mice strongly suggests that T cells recognize a very limited number of epitopes on the envelope antigen. For most of the variety of antigens tested, the immune responsiveness of coisogenic C57BL/6 (B6) and bm12 mice were found to be indistinguishable (summarized in reference 54). H-Y antigen and beef insulin are the only two exceptions where bm12 mice are nonresponders and B6 are responders (54) . Interestingly, analyses using heterologous insulins (54, 55) have demonstrated that only one amino acid change between beef and sheep insulins is responsible for the different immune responsiveness between bm12 and B6 mice . Therefore, it is possible that T cell repertoire for recognition of FMuLV envelope protein is restricted to only one epitope defined by a few amino acid(s). Comparison of T cell responsiveness to endogenous versus exogenous retroviral envelope proteins in H-26 and H-2`1 2 mice might provide further evidence to evaluate this hypothesis .
The Ir gene control ofT cell responsiveness to FMuLV envelope protein described here is completely consistent with our previous results of in vivo immune protection experiments (25, 26) . In fact, the mice having the responder b allele at I region loci of the H-2 are protectively immunized against FV with the vaccinia-FMuLV env recombinant vaccine, while the mice having only the nonresponder k allele in these loci are not protected (26) . Since it has previously been shown that the protective immunity against FV is functionally associated with priming of helper T cells with FMuLV envelope (25, 26) , it is now quite appropriate to conclude that the Ir genes for FMuLV envelope protein do control the induction ofhelper T cells in vivo. However, the role of the same Ir genes in spontaneous recovery from FVinduced leukemia is still unclear. Our previous studies (17, 19) have demonstrated that the H-2D locus strongly influences spontaneous recovery from FVinduced splenomegaly. This influence appears to act by controlling the time course of the development of Friend leukemia cell-specific T cell proliferative response in FVinfected mice (24) . The mechanism by which the H-2D locus influences the dynamics of T cell response is unknown. However, the mice having the d/b or d/d allele at the D locus do not recover from high-dose inoculation of FV even when they have the responder b allele at the H-2I region (Table I) . Therefore, the effect ofH-2D locus is apparently stronger than that of the Ir genes to FMuLV envelope. Interestingly, when inoculated with a low dose of FV, H-2alb as well as H-2' mice recover spontaneously from splenomegaly, while H-2°l°mice do not (Table I) . We are currently examining whether there is a possible requirement for the responder b allele at H-2I for spontaneous recovery of H-2D Ib mice from low-dose inoculation of FV.
Finally, one recent study (56) suggested that similar Ir gene phenomenon might control the T cell responsiveness in humans against human Tlymphotropic virus type-I (HTLVI) . Low responsiveness of T cells against the human retrovirus was associated with the development of leukemia (56) . Based on our present results, low responsiveness of T cells to retroviral antigens may also cause lack of or insufficient protective immunity after immunization . Therefore, it will probably be necessary to overcome genetic restrictions of the antiretrovirus immune response when attempting to induce protective immunity against human retrovirus infection. In this regard, our previous study (26) demonstrated that nonresponders to FMuLV envelope protein could be protected against FV when they were immunized with fixed FMuLV particles in CFA. Furthermore, alow, but significant, level of T cell proliferative response under the stimulation of H-2"°PEC was observed when the H-2°~b mice were immunized with purified RMuLV virions in CFA ( Fig . 1 and Table II ). This apparent bypassing of the Ir gene phenomenon might be due to immunization of mice with larger amounts of antigen, use of highly immunostimulatory adjuvant, or simply due to the priming of T cells with the gag and/or pol gene products . This latter possibility is currently being tested by using recombinant vaccinia viruses that express the FMuLV gag gene . 
